Skip to main content

Animations

MJFF Publications

5121 - 5130 of 6617 Results
Title
Year
  • Year
  • 2017
  • 2019
  • 2020
  • 2021
  • 2023
  • 2020
  • 2024
  • 2024
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease Models
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068
    Citation Count: 131
  • Summary Details
    OPEN
    Title: Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25629
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2020.105728
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Single‐Molecule Counting Coupled to Rapid Amplification Enables Detection of α‐Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/anie.202014898
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51753
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28382
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00748-5
    Citation Count: 18
  • Summary Details
    OPEN
    Title: A data-driven single-cell and spatial transcriptomic map of the human prefrontal cortex
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.adh1938
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Mitochondrial damage triggers the concerted degradation of negative regulators of neuronal autophagy
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-62379-5
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-53168-7
    Citation Count: 32
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.